Skip to main content
. 2018 Apr 17;9(29):20467–20475. doi: 10.18632/oncotarget.24943

Figure 2. Fragment sizes of plasma cfDNA in RCC patients were shorter than those in healthy controls.

Figure 2

(A) The cfDNA fragment size was quantified by a microfluidics-based platform. Comparison of fragment sizes of plasma cfDNA between healthy controls (n = 41) and RCC patients (n = 92). (Wilcoxon test). (B) The cfDNA fragment size was significantly shorter with Fuhrman nuclear grade 3 and 4 (high grade) than without grade 3 and 4 (low grade) (n = 68). **p < 0.01 (Wilcoxon test). (C) The cfDNA fragment size was significantly shorter with positive LVI than negative (n = 68). **p < 0.01 (Wilcoxon test).